Minisymposium Schedule and Suggested References

Conjoint 538, Winter 2004

 

Minisymposium, Session I

 

RAD51

Henry-Mowatt et al., 2003

Alexiadis and Kadonaga, 2002

Pellegrini et al., 2002

 

RAD52/54

Essers et al., 2002

Solinger et al., 2002

 

BRCA1

Vandenberg et al., 2003

Dong et al., 2003

Rothfuss and Grompe, 2004

Taniguchi et al., 2003

 

BRCA2

Dong et al., 2003

            Pellegrini et al., 2002

            Hirsch et al., 2003

Howlett et al., 2002

Rothfuss and Grompe, 2004

Taniguchi et al., 2003

 

FANC

Meetei et al., 2003b

Hirsch et al., 2003

Levitus et al., 2003

Rothfuss and Grompe, 2004

Taniguchi et al., 2003

 

FANC D

Nakanishi et al., 2002

Houghtaling et al., 2003

Hirsch et al., 2003

Liu et al., 2003

Vandenberg et al., 2003

 

MSH2/MSH6/EXO1

Wei et al., 2003

 

XRCC1

Whitehouse et al., 2001      

Vidal et al., 2001

           

Minisymposium, Session II

 

MUS81/EME1

Abraham et al., 2003

Boddy et al., 2001

Chen et al., 2001

Ogrunc and Sancar, 2003

 

WRN

            Saintigny et al., 2002

            Baynton et al., 2003

 

            BLM

Wu and Hickson, 2003

Fabre et al., 2002

Meetei et al., 2003b

Goss et al., 2002

 

Ku/DNA-PK/Artemis

Karanjawala et al., 2002

Ma et al., 2002

 

DNA LIGASE 4

Frank et al., 2000

O'Driscoll et al., 2001

 

RAG1/2

Messier et al., 2003

Jones and Gellert, 2003

 

H2AX

Bassing et al., 2003

Celeste et al., 2002

 

MRE11/RAD50/NBS1

Bender et al., 2002

Hopfner et al., 2002

Carson et al., 2003; Stracker et al., 2002

Bender et al., 2002

Uziel et al., 2003

Nakanishi et al., 2002

           

 

 

Minisymposium, Session III

 

AID

Petersen-Mahrt et al., 2002

Chaudhuri et al., 2003

 

APOBECS

Mangeat et al., 2003

 

UNG

Imai et al., 2003

Rada et al., 2002

Di Noia and Neuberger, 2002

 

Error-prone Polymerases

Pol eta

Bresson and Fuchs, 2002

Zheng et al., 2003

 

Pol iota

Kannouche et al., 2002

Faili et al., 2002

 

RAD51 Paralogues

Liu et al., 2002

Masson et al., 2001

Sale et al., 2001

 

            RAD51C/XRCC3

Liu et al., 2004

 

Minisymposium, Session IV

 

TFIIH

Iben et al., 2002

Bradsher et al., 2002

Riedl et al., 2003

Tremeau-Bravard et al., 2003

Dubaele et al., 2003

 

CSB

Osterod et al., 2002

Bradsher et al., 2002

 

XPD

de Boer et al., 2002

Dubaele et al., 2003

Vermeulen et al., 2001

 

ERCC1/XPF

Zhu et al., 2003

Niedernhofer et al., 2001

 

XPG

Reardon and Sancar, 2002

Lee et al., 2002

Emmert et al., 2002

Lalle et al., 2002

 

Ubiquitin, Sumo

Mallery et al., 2002

Meetei et al., 2003a

Jones and Gellert, 2003

Bachant et al., 2002

 

ATM

Bakkenist and Kastan, 2003

Spring et al., 2002

Carson et al., 2003

Uziel et al., 2003

 

ATR

Costanzo et al., 2003

Casper et al., 2002

 

P53

Zhu et al., 2002

Sorlie et al., 2003

Leslie et al., 2003; Overholtzer et al., 2003

Liu et al., 2003

 

 

 

BIBLIOGRAPHY

 

Abraham, J., Lemmers, B., Hande, M. P., Moynahan, M. E., Chahwan, C., Ciccia, A., Essers, J., Hanada, K., Chahwan, R., Khaw, A. K., et al. (2003). Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells. Embo J 22, 6137-6147.

Alexiadis, V., and Kadonaga, J. T. (2002). Strand pairing by Rad54 and Rad51 is enhanced by chromatin. Genes Dev 16, 2767-2771.

Bachant, J., Alcasabas, A., Blat, Y., Kleckner, N., and Elledge, S. J. (2002). The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Mol Cell 9, 1169-1182.

Bakkenist, C. J., and Kastan, M. B. (2003). DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506.

Bassing, C. H., Suh, H., Ferguson, D. O., Chua, K. F., Manis, J., Eckersdorff, M., Gleason, M., Bronson, R., Lee, C., and Alt, F. W. (2003). Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114, 359-370.

Baynton, K., Otterlei, M., Bjoras, M., von Kobbe, C., Bohr, V. A., and Seeberg, E. (2003). WRN interacts physically and functionally with the recombination mediator protein RAD52. J Biol Chem 278, 36476-36486.

Bender, C. F., Sikes, M. L., Sullivan, R., Huye, L. E., Le Beau, M. M., Roth, D. B., Mirzoeva, O. K., Oltz, E. M., and Petrini, J. H. (2002). Cancer predisposition and hematopoietic failure in Rad50(S/S) mice. Genes Dev 16, 2237-2251.

Boddy, M. N., Gaillard, P. H., McDonald, W. H., Shanahan, P., Yates, J. R., 3rd, and Russell, P. (2001). Mus81-Eme1 are essential components of a Holliday junction resolvase. Cell 107, 537-548.

Bradsher, J., Auriol, J., Proietti de Santis, L., Iben, S., Vonesch, J. L., Grummt, I., and Egly, J. M. (2002). CSB is a component of RNA pol I transcription. Mol Cell 10, 819-829.

Bresson, A., and Fuchs, R. P. (2002). Lesion bypass in yeast cells: Pol eta participates in a multi-DNA polymerase process. Embo J 21, 3881-3887.

Carson, C. T., Schwartz, R. A., Stracker, T. H., Lilley, C. E., Lee, D. V., and Weitzman, M. D. (2003). The Mre11 complex is required for ATM activation and the G(2)/M checkpoint. Embo J 22, 6610-6620.

Casper, A. M., Nghiem, P., Arlt, M. F., and Glover, T. W. (2002). ATR regulates fragile site stability. Cell 111, 779-789.

Celeste, A., Petersen, S., Romanienko, P. J., Fernandez-Capetillo, O., Chen, H. T., Sedelnikova, O. A., Reina-San-Martin, B., Coppola, V., Meffre, E., Difilippantonio, M. J., et al. (2002). Genomic instability in mice lacking histone H2AX. Science 296, 922-927.

Chaudhuri, J., Tian, M., Khuong, C., Chua, K., Pinaud, E., and Alt, F. W. (2003). Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422, 726-730.

Chen, X. B., Melchionna, R., Denis, C. M., Gaillard, P. H., Blasina, A., Van de Weyer, I., Boddy, M. N., Russell, P., Vialard, J., and McGowan, C. H. (2001). Human Mus81-associated endonuclease cleaves Holliday junctions in vitro. Mol Cell 8, 1117-1127.

Costanzo, V., Shechter, D., Lupardus, P. J., Cimprich, K. A., Gottesman, M., and Gautier, J. (2003). An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol Cell 11, 203-213.

de Boer, J., Andressoo, J. O., de Wit, J., Huijmans, J., Beems, R. B., van Steeg, H., Weeda, G., van der Horst, G. T., van Leeuwen, W., Themmen, A. P., et al. (2002). Premature aging in mice deficient in DNA repair and transcription. Science 296, 1276-1279.

Di Noia, J., and Neuberger, M. S. (2002). Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419, 43-48.

Dong, Y., Hakimi, M. A., Chen, X., Kumaraswamy, E., Cooch, N. S., Godwin, A. K., and Shiekhattar, R. (2003). Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol Cell 12, 1087-1099.

Dubaele, S., Proietti De Santis, L., Bienstock, R. J., Keriel, A., Stefanini, M., Van Houten, B., and Egly, J. M. (2003). Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol Cell 11, 1635-1646.

Emmert. S., Slor, H., Busch, D.B., Batko, S., Albert, R.B., Coleman, D., Khan, S.G., Abu-Libdeh, B., DiGiovanna, J.J., Cunningham, B.B., Lee, M.M., Crollick, J., Inui, H., Ueda, T., Hedayati, M., Grossman, L., Shahlavi, T., Cleaver, J.E., Kraemer, K.H. (2002) Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J Invest Dermatol. 118, 972-82. Erratum in: J Invest Dermatol.

(2003 ) 120, 173..

Essers, J., Houtsmuller, A. B., van Veelen, L., Paulusma, C., Nigg, A. L., Pastink, A., Vermeulen, W., Hoeijmakers, J. H., and Kanaar, R. (2002). Nuclear dynamics of RAD52 group homologous recombination proteins in response to DNA damage. Embo J 21, 2030-2037.

Fabre, F., Chan, A., Heyer, W. D., and Gangloff, S. (2002). Alternate pathways involving Sgs1/Top3, Mus81/ Mms4, and Srs2 prevent formation of toxic recombination intermediates from single-stranded gaps created by DNA replication. Proc Natl Acad Sci U S A 99, 16887-16892.

Faili, A., Aoufouchi, S., Flatter, E., Gueranger, Q., Reynaud, C. A., and Weill, J. C. (2002). Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota. Nature 419, 944-947.

Frank, K. M., Sharpless, N. E., Gao, Y., Sekiguchi, J. M., Ferguson, D. O., Zhu, C., Manis, J. P., Horner, J., DePinho, R. A., and Alt, F. W. (2000). DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell 5, 993-1002.

Goss, K. H., Risinger, M. A., Kordich, J. J., Sanz, M. M., Straughen, J. E., Slovek, L. E., Capobianco, A. J., German, J., Boivin, G. P., and Groden, J. (2002). Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297, 2051-2053.

Henry-Mowatt, J., Jackson, D., Masson, J. Y., Johnson, P. A., Clements, P. M., Benson, F. E., Thompson, L. H., Takeda, S., West, S. C., and Caldecott, K. W. (2003). XRCC3 and Rad51 modulate replication fork progression on damaged vertebrate chromosomes. Mol Cell 11, 1109-1117.

Hirsch, B., Shimamura, A., Moreau, L., Baldinger, S., Hag-Alshiekh, M., Bostrom, B., Sencer, S., and D'Andrea, A. D. (2003). Biallelic BRCA2/FANCD1 mutations: association with spontaneous chromosomal instability and solid tumors of childhood. Blood.

Hopfner, K. P., Craig, L., Moncalian, G., Zinkel, R. A., Usui, T., Owen, B. A., Karcher, A., Henderson, B., Bodmer, J. L., McMurray, C. T., et al. (2002). The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Nature 418, 562-566.

Houghtaling, S., Timmers, C., Noll, M., Finegold, M. J., Jones, S. N., Meyn, M. S., and Grompe, M. (2003). Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev 17, 2021-2035.

Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., De Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002). Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606-609.

Iben, S., Tschochner, H., Bier, M., Hoogstraten, D., Hozak, P., Egly, J. M., and Grummt, I. (2002). TFIIH plays an essential role in RNA polymerase I transcription. Cell 109, 297-306.

Imai, K., Slupphaug, G., Lee, W. I., Revy, P., Nonoyama, S., Catalan, N., Yel, L., Forveille, M., Kavli, B., Krokan, H. E., et al. (2003). Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4, 1023-1028.

Jones, J. M., and Gellert, M. (2003). Autoubiquitylation of the V(D)J recombinase protein RAG1. Proc Natl Acad Sci U S A.

Kannouche, P., Fernandez de Henestrosa, A. R., Coull, B., Vidal, A. E., Gray, C., Zicha, D., Woodgate, R., and Lehmann, A. R. (2002). Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells. Embo J 21, 6246-6256.

Karanjawala, Z. E., Adachi, N., Irvine, R. A., Oh, E. K., Shibata, D., Schwarz, K., Hsieh, C. L., and Lieber, M. R. (2002). The embryonic lethality in DNA ligase IV-deficient mice is rescued by deletion of Ku: implications for unifying the heterogeneous phenotypes of NHEJ mutants. DNA Repair (Amst) 1, 1017-1026.

Lalle P, Nouspikel T, Constantinou A, Thorel F, Clarkson SG. (2002) The founding members of xeroderma pigmentosum group G produce XPG proteiN with severely impaired endonuclease activity. J Invest Dermatol. 118, 344-51.

Lee, S. K., Yu, S. L., Prakash, L., and Prakash, S. (2002). Requirement of yeast RAD2, a homolog of human XPG gene, for efficient RNA polymerase II transcription. implications for Cockayne syndrome. Cell 109, 823-834.

Leslie, A., Pratt, N. R., Gillespie, K., Sales, M., Kernohan, N. M., Smith, G., Wolf, C. R., Carey, F. A., and Steele, R. J. (2003). Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas. Cancer Res 63, 4656-4661.

Levitus, M., Rooimans, M. A., Steltenpool, J., Cool, N. F., Oostra, A. B., Mathew, C. G., Hoatlin, M. E., Waisfisz, Q., Arwert, F., De Winter, J. P., and Joenje, H. (2003). Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood.

Liu, N., Schild, D., Thelen, M. P., and Thompson, L. H. (2002). Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells. Nucleic Acids Res 30, 1009-1015.

Liu, T. X., Howlett, N. G., Deng, M., Langenau, D. M., Hsu, K., Rhodes, J., Kanki, J. P., D'Andrea, A. D., and Look, A. T. (2003). Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis. Dev Cell 5, 903-914.

Liu, Y., Masson, J. Y., Shah, R., O'Regan, P., and West, S. C. (2004). RAD51C is required for Holliday junction processing in mammalian cells. Science 303.

Ma, Y., Pannicke, U., Schwarz, K., and Lieber, M. R. (2002). Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108, 781-794.

Mallery, D. L., Vandenberg, C. J., and Hiom, K. (2002). Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. Embo J 21, 6755-6762.

Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003). Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103.

Masson, J. Y., Tarsounas, M. C., Stasiak, A. Z., Stasiak, A., Shah, R., McIlwraith, M. J., Benson, F. E., and West, S. C. (2001). Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev 15, 3296-3307.

Meetei, A. R., de Winter, J. P., Medhurst, A. L., Wallisch, M., Waisfisz, Q., van de Vrugt, H. J., Oostra, A. B., Yan, Z., Ling, C., Bishop, C. E., et al. (2003a). A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 35, 165-170.

Meetei, A. R., Sechi, S., Wallisch, M., Yang, D., Young, M. K., Joenje, H., Hoatlin, M. E., and Wang, W. (2003b). A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol 23, 3417-3426.

Messier, T. L., O'Neill, J. P., Hou, S. M., Nicklas, J. A., and Finette, B. A. (2003). In vivo transposition mediated by V(D)J recombinase in human T lymphocytes. Embo J 22, 1381-1388.

Nakanishi, K., Taniguchi, T., Ranganathan, V., New, H. V., Moreau, L. A., Stotsky, M., Mathew, C. G., Kastan, M. B., Weaver, D. T., and D'Andrea, A. D. (2002). Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 4, 913-920.

Niedernhofer, L. J., Essers, J., Weeda, G., Beverloo, B., de Wit, J., Muijtjens, M., Odijk, H., Hoeijmakers, J. H., and Kanaar, R. (2001). The structure-specific endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic stem cells. Embo J 20, 6540-6549.

O'Driscoll, M., Cerosaletti, K. M., Girard, P. M., Dai, Y., Stumm, M., Kysela, B., Hirsch, B., Gennery, A., Palmer, S. E., Seidel, J., et al. (2001). DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 8, 1175-1185.

Ogrunc, M., and Sancar, A. (2003). Identification and characterization of human MUS81-MMS4 structure-specific endonuclease. J Biol Chem 278, 21715-21720.

Osterod, M., Larsen, E., Le Page, F., Hengstler, J. G., Van Der Horst, G. T., Boiteux, S., Klungland, A., and Epe, B. (2002). A global DNA repair mechanism involving the Cockayne syndrome B (CSB) gene product can prevent the in vivo accumulation of endogenous oxidative DNA base damage. Oncogene 21, 8232-8239.

Overholtzer, M., Rao, P. H., Favis, R., Lu, X. Y., Elowitz, M. B., Barany, F., Ladanyi, M., Gorlick, R., and Levine, A. J. (2003). The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci U S A 100, 11547-11552.

Pellegrini, L., Yu, D. S., Lo, T., Anand, S., Lee, M., Blundell, T. L., and Venkitaraman, A. R. (2002). Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 420, 287-293.

Petersen-Mahrt, S. K., Harris, R. S., and Neuberger, M. S. (2002). AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-104.

Rada, C., Williams, G. T., Nilsen, H., Barnes, D. E., Lindahl, T., and Neuberger, M. S. (2002). Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol 12, 1748-1755.

Reardon, J. T., and Sancar, A. (2002). Molecular anatomy of the human excision nuclease assembled at sites of DNA damage. Mol Cell Biol 22, 5938-5945.

Riedl, T., Hanaoka, F., and Egly, J. M. (2003). The comings and goings of nucleotide excision repair factors on damaged DNA. Embo J 22, 5293-5303.

Rothfuss, A., and Grompe, M. (2004). Repair Kinetics of Genomic Interstrand DNA Cross-Links: Evidence for DNA Double-Strand Break-Dependent Activation of the Fanconi Anemia/BRCA Pathway. Mol Cell Biol 24, 123-134.

Saintigny, Y., Makienko, K., Swanson, C., Emond, M. J., and Monnat, R. J., Jr. (2002). Homologous recombination resolution defect in werner syndrome. Mol Cell Biol 22, 6971-6978.

Sale, J. E., Calandrini, D. M., Takata, M., Takeda, S., and Neuberger, M. S. (2001). Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature 412, 921-926.

Solinger, J. A., Kiianitsa, K., and Heyer, W. D. (2002). Rad54, a Swi2/Snf2-like recombinational repair protein, disassembles Rad51:dsDNA filaments. Mol Cell 10, 1175-1188.

Sorlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100, 8418-8423.

Spring, K., Ahangari, F., Scott, S. P., Waring, P., Purdie, D. M., Chen, P. C., Hourigan, K., Ramsay, J., McKinnon, P. J., Swift, M., and Lavin, M. F. (2002). Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat Genet 32, 185-190.

Stracker, T. H., Carson, C. T., and Weitzman, M. D. (2002). Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418, 348-352.

Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S. V., Mathew, C. G., Joenje, H., Mok, S. C., and D'Andrea, A. D. (2003). Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 9, 568-574.

Tremeau-Bravard, A., Riedl, T., Egly, J. M., and Dahmus, M. E. (2003). Fate of RNA polymerase II stalled at a cisplatin lesion. J Biol Chem.

Uziel, T., Lerenthal, Y., Moyal, L., Andegeko, Y., Mittelman, L., and Shiloh, Y. (2003). Requirement of the MRN complex for ATM activation by DNA damage. Embo J 22, 5612-5621.

Vandenberg, C. J., Gergely, F., Ong, C. Y., Pace, P., Mallery, D. L., Hiom, K., and Patel, K. J. (2003). BRCA1-independent ubiquitination of FANCD2. Mol Cell 12, 247-254.

Vermeulen, W., Rademakers, S., Jaspers, N. G., Appeldoorn, E., Raams, A., Klein, B., Kleijer, W. J., Hansen, L. K., and Hoeijmakers, J. H. (2001). A temperature-sensitive disorder in basal transcription and DNA repair in humans. Nat Genet 27, 299-303.

Vidal, A. E., Boiteux, S., Hickson, I. D., and Radicella, J. P. (2001). XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. Embo J 20, 6530-6539.

Wei, K., Clark, A. B., Wong, E., Kane, M. F., Mazur, D. J., Parris, T., Kolas, N. K., Russell, R., Hou, H., Jr., Kneitz, B., et al. (2003). Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes Dev 17, 603-614.

Whitehouse, C. J., Taylor, R. M., Thistlethwaite, A., Zhang, H., Karimi-Busheri, F., Lasko, D. D., Weinfeld, M., and Caldecott, K. W. (2001). XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 104, 107-117.

Wu, L., and Hickson, I. D. (2003). The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature 426, 870-874.

Zheng, H., Wang, X., Warren, A. J., Legerski, R. J., Nairn, R. S., Hamilton, J. W., and Li, L. (2003). Nucleotide excision repair- and polymerase eta-mediated error-prone removal of mitomycin C interstrand cross-links. Mol Cell Biol 23, 754-761.

Zhu, C., Mills, K. D., Ferguson, D. O., Lee, C., Manis, J., Fleming, J., Gao, Y., Morton, C. C., and Alt, F. W. (2002). Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109, 811-821.

Zhu, X. D., Niedernhofer, L., Kuster, B., Mann, M., Hoeijmakers, J. H., and de Lange, T. (2003). ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 12, 1489-1498.